Clinical Trial Detail

NCT ID NCT02118285
Title Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements no
Sponsors Masonic Cancer Center, University of Minnesota
Indications

ovarian cancer

fallopian tube cancer

peritoneum cancer

Therapies

Aldesleukin

Epacadostat

Cyclophosphamide

Fludarabine

Age Groups: adult

No variant requirements are available.